n-(2-(diethylamino)ethyl)-4-iodobenzamide has been researched along with Malignant Melanoma in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (66.67) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eisenhut, M; Gorgas, K; Haberkorn, U; Hull, WE; Just, W; Lay, D; Lehmann, WD; Mier, W; Mohammed, A | 1 |
| Bacin, F; Bonafous, J; Chossat, F; D'Incan, M; Kemeny, JL; Mestas, D; Moins, N; Sillaire-Houtmann, I; Veyre, A | 1 |
| Chéhadé, F; de Labriolle-Vaylet, C; Galle, P; Hindié, E; Labarre, P; Moins, N; Moreau, MF; Papon, J; Veyre, A | 1 |
| Barety, M; Bonafous, JF; Bussière, F; Darcourt, J; Lacour, JP; Michelot, JM; Migneco, O; Rodot, S; Schneider, M; Thyss, A | 1 |
| Bacin, FJ; Bonafous, JF; Bussiere, F; Chossat, FM; Madelmont, JC; Mauclaire, LP; Michelot, JM; Moreau, MF; Souteyrand, PA; Veyre, AJ | 1 |
| Jeong, JM; John, CS; Kinuya, S; Le, N; McAfee, JG; Paik, CH; Reba, RC; Saga, T; Varma, VM | 1 |
| Bartenstein, P; Brandau, W; Kamanabrou, D; Kirchner, B; Schober, O; Sciuk, J | 1 |
| Bayle, M; Boire, JY; Labarre, P; Madelmont, JC; Michelot, J; Moins, N; Moreau, MF; Papon, J; Parry, D; Seguin, H | 1 |
| Bossuyt, A; Everaert, H; Flamen, P; Franken, PR; Mertens, J | 1 |
| Bossuyt, A; Everaert, H; Hennekes, R; Lodewijks, H | 1 |
| Bacin, F; Bekhechi, D; Bonafous, J; Chossat, F; Kemeny, JL; Michelot, J; Moreau, MF; Veyre, A | 1 |
| Brandau, W; Coenen, HH; Dittmann, H; Dutschka, K; Streffer, C; Zölzer, F | 1 |
| Chehade, F; De Labriolle-Vaylet, C; Escaig, F; Galle, P; Hindié, E; Michelot, J; Moins, N; Moreau, MF; Papon, J; Veyre, A | 1 |
| Bayle, M; Labarre, P; Madelmont, JC; Moins, N; Moreau, MF; Papon, J; Veyre, A | 1 |
| Meyniel, G; Michelot, J; Moreau, MF; Veyre, A | 1 |
4 trial(s) available for n-(2-(diethylamino)ethyl)-4-iodobenzamide and Malignant Melanoma
| Article | Year |
|---|---|
[Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma].
Topics: Benzamides; Choroid Neoplasms; Ciliary Body; Conjunctival Neoplasms; Diagnosis, Differential; Eye Neoplasms; Female; Humans; Iodine Radioisotopes; Liver Neoplasms; Male; Melanoma; Ophthalmoscopy; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed; Ultrasonography; Uveal Neoplasms | 2004 |
A radiolabelled iodobenzamide for malignant melanoma staging.
Topics: Aged; Aged, 80 and over; Benzamides; Chemotherapy, Adjuvant; Choroid Neoplasms; Combined Modality Therapy; False Negative Reactions; False Positive Reactions; Female; Humans; Iodine Radioisotopes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Neoplasm Staging; Neoplasms, Unknown Primary; Radionuclide Imaging; Remission Induction; Skin Neoplasms | 1994 |
Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzamides; Female; Humans; Iodine Radioisotopes; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Radionuclide Imaging; Sensitivity and Specificity | 1993 |
Clinical study of [123I] N-(2-diethylaminoethyl)-4-iodobenzamide in the diagnosis of primary and metastatic ocular melanoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzamides; Brachytherapy; Conjunctival Neoplasms; Contrast Media; Eye Enucleation; Female; Humans; Laser Coagulation; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Middle Aged; Radionuclide Imaging; Sensitivity and Specificity; Uveal Neoplasms | 1998 |
11 other study(ies) available for n-(2-(diethylamino)ethyl)-4-iodobenzamide and Malignant Melanoma
| Article | Year |
|---|---|
Radioiodinated N-(2-diethylaminoethyl)benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization.
Topics: Animals; Benzamides; Brain; Centrifugation, Density Gradient; Chromatography, High Pressure Liquid; Contrast Media; Guinea Pigs; In Vitro Techniques; Iodine Radioisotopes; Iodobenzenes; Liver; Mass Spectrometry; Melanins; Melanoma; Mice; Mice, Inbred C57BL; Rats; Receptors, sigma; Structure-Activity Relationship; Tumor Cells, Cultured | 2000 |
Secondary ion mass spectrometry as a tool for investigating radiopharmaceutical distribution at the cellular level: the example of I-BZA and (14)C-I-BZA.
Topics: Animals; Benzamides; Carbon Radioisotopes; Male; Melanoma; Mice; Mice, Inbred C57BL; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Spectrometry, Mass, Secondary Ion; Tissue Distribution | 2005 |
An improved synthesis of [125I]N-(diethylaminoethyl)-4-iodobenzamide: a potential ligand for imaging malignant melanoma.
Topics: Animals; Benzamides; Contrast Media; Humans; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Radionuclide Imaging; Tissue Distribution; Tumor Cells, Cultured | 1993 |
N-(2-diethylaminoethyl)-4-[123I]iodobenzamide as a tracer for the detection of malignant melanoma: simple synthesis, improved labelling technique and first clinical results.
Topics: Aged; Benzamides; Chromatography, High Pressure Liquid; Contrast Media; Female; Humans; Iodine Radioisotopes; Isotope Labeling; Male; Melanoma; Middle Aged; Radioimmunodetection; Skin Neoplasms; Technetium Tc 99m Pentetate | 1993 |
Synthesis, radiolabeling, and preliminary evaluation in mice of some (N-diethylaminoethyl)-4-iodobenzamide derivatives as melanoma imaging agents.
Topics: Animals; Benzamides; Humans; Indicators and Reagents; Iodine Radioisotopes; Isotope Labeling; Magnetic Resonance Spectroscopy; Male; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Radionuclide Imaging; Tissue Distribution | 1995 |
Visualizing ocular melanoma using iodine-123-N-(2-diethylaminoethyl)4-iodobenzamide SPECT.
Topics: Benzamides; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Male; Melanoma; Middle Aged; Nevus; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Uveal Neoplasms | 1997 |
I-123-IDAB: a new tracer for scintigraphic visualisation of malignant melanoma.
Topics: Aged; Benzamides; Choroid Neoplasms; Contrast Media; Female; Humans; Iris Neoplasms; Male; Melanoma; Middle Aged; Neoplasm Invasiveness; Radionuclide Imaging | 1996 |
In vitro studies on the cellular uptake of melanoma imaging aminoalkyl-iodobenzamide derivatives (ABA).
Topics: Benzamides; Iodine Radioisotopes; Iodobenzoates; Melanins; Melanoma; Models, Biological; Radionuclide Imaging; Radiopharmaceuticals; Receptors, sigma; Sensitivity and Specificity; Structure-Activity Relationship; Tumor Cells, Cultured | 1999 |
Distribution of I-BZA (N-2-diethylaminoethyl-4-iodobenzamide) in grafted melanoma and normal skin: a study by secondary ion mass spectroscopy.
Topics: Animals; Benzamides; Lung Neoplasms; Male; Melanins; Melanoma; Mice; Neoplasm Transplantation; Organ Specificity; Skin; Spectrometry, Mass, Secondary Ion; Tumor Cells, Cultured | 2001 |
Melanin affinity of N-(2-diethylaminoethyl)-4-iodobenzamide, an effective melanoma imaging agent.
Topics: Benzamides; Binding Sites; Cells, Cultured; Humans; Iodine Radioisotopes; Melanins; Melanoma; Skin Neoplasms; Tumor Cells, Cultured | 2002 |
[Perspectives of scintigraphic diagnosis of malignant lymphoma using a new radiopharmaceutical].
Topics: Animals; Benzamides; Contrast Media; Melanoma; Methods; Mice; Mice, Inbred C57BL; Mice, Nude; Radionuclide Imaging | 1990 |